Inside the IQM Quantum Computers SPAC Deal: valuation, dilution, close
IQM Quantum Computers, the Finland-based superconducting quantum hardware company, has gone public through a merger with Real Asset Acquisition Corp. The combined company began trading on Nasdaq as IQMX on July 2, 2026, with the warrant line under IQMX WS. The setup is compelling for believers in early quantum adoption, but shareholders should watch dilution, warrant overhang, and how much trust cash actually made it through at close.
IQM Quantum Computers, the Finland-based superconducting quantum hardware company, has gone public through a merger with Real Asset Acquisition Corp. The combined company began trading on Nasdaq as IQMX on July 2, 2026, with the warrant line under IQMX WS. The setup is compelling for believers in early quantum adoption, but shareholders should watch dilution, warrant overhang, and how much trust cash actually made it through at close.
IQM Quantum Computers was founded in 2018 and is headquartered in Espoo, Finland. It describes itself as a global leader in full-stack, superconducting quantum computers, and its business model is vertically integrated: it designs chips, develops software, operates a chip fab and assembly line, and runs a data center. IQM sells full-stack quantum systems that can be deployed on-premise or accessed through the cloud, serving enterprises, research institutions, universities, high-performance computing centers, and national laboratories.
By the deal materials, IQM had sold 23 systems as of the May 14, 2026 announcement, and later disclosed 26 full-stack quantum computers sold globally, more than 50 systems built, 17 delivered, and 8 in production as of June 30, 2026. The company also said it had over 350 employees across Europe, Asia, and North America. The industry backdrop is still early-stage: IQM’s investor materials frame quantum computing as a market with $1T+ of potential economic value by 2040, but commercialization remains volatile and adoption is still developing.
The SPAC Deal
This de-SPAC valued IQM at about $1.8 billion pre-money equity value and roughly $1.7 billion pro forma enterprise value. The sources-and-uses slide showed $175 million of trust cash, $172 million of IQM cash, $134 million of PIPE financing, and $24 million of expected warrant exercise proceeds, offset by about $25 million of transaction fees and expenses. On paper, the deal pointed to about $480 million of pro forma cash to the balance sheet, but that figure assumed no redemptions.
That redemption assumption is the key SPAC wrinkle. RAAQ’s trust was approximately $175 million, but the filing modeled 0% redemptions in the headline cash-at-close math, and the materials reviewed did not disclose actual redemption levels. The financing package also included dilution from founder shares, PIPE shares, and warrants. RAAQ public shareholders were modeled at about 17.25 million shares, founder shares vested at close at about 4.38 million, and PIPE investors at about 13.43 million shares, with warrants assumed by IQM at close and exercisable at $11.50 per share. The transaction is already closed: RAAQ shareholders approved it on June 25, 2026, the business combination was completed on July 1, 2026, and trading in IQM ADSs began on July 2, 2026. The current SPAC ticker was RAAQ, and the combined company now trades as IQMX; the warrant line is IQMX WS.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
The SPAC route gave IQM a faster path to public markets while letting it highlight forward-looking growth plans and the scale of the quantum opportunity to investors. The deal materials emphasize that the company is still in heavy investment mode, so the public listing helps fund continued manufacturing, system deployment, software development, and commercial expansion without waiting for a traditional IPO window.
The transaction also brought in committed capital and sponsor backing at a time when quantum hardware remains a thematic but still early market. For a company like IQM, the appeal of a de-SPAC is not just listing speed; it is also the ability to package a long-duration story around projected market expansion, customer traction, and balance-sheet funding in one transaction.
Financial Highlights
IQM’s disclosed top line is still small relative to its valuation, but it is growing. The deal materials cite 2025 revenue of $36 million in one press release, while the investor deck and related materials refer to at least $35 million of 2025E unaudited revenue. The company also disclosed over $100 million in bookings or visibility as of year-end 2025, which is important because quantum hardware sales can be lumpy and long-cycle.
Profitability is not the story here. The materials reviewed do not provide a full audited income statement in the excerpt, but they clearly show IQM is still loss-making and investing aggressively in manufacturing, software, and commercialization. On the balance sheet, IQM had $172 million in cash at year-end 2025, and the deal materials pointed to roughly $480 million of pro forma cash at close assuming no redemptions. That gives the company more runway, but the actual amount depends on how many SPAC shareholders redeemed.
Risk Factors
The biggest de-SPAC-specific risk is redemption leakage. RAAQ’s trust was about $175 million, but the cash-at-close math assumed 0% redemptions, and the filing did not disclose actual redemption levels in the materials reviewed. If redemptions were meaningful, the company would have to rely more heavily on the PIPE and other financing to reach the expected cash balance.
Dilution is the other major issue. Public shareholders, founder shares, PIPE shares, and warrants all add to the share count, and the warrant overhang is material because RAAQ warrants convert into IQM ADS warrants at $11.50. Beyond the capital structure, the core business risks are just as important: quantum computing is still early, customer adoption may scale slower than expected, the company depends heavily on key personnel, and execution risk remains high in a technically complex market. Shareholders should also watch whether the company can convert bookings into repeatable revenue without burning through the new cash too quickly.
Comparable Public Companies
The closest public comps are the small set of listed quantum computing names: IonQ (IONQ), Rigetti Computing (RGTI), D-Wave Quantum (QBTS), Quantum Computing Inc. (QUBT), and Arqit Quantum (ARQQ). IQM’s deck frames these as the relevant peer set, while also noting that large platform players remain in the broader competitive landscape.
As a group, these stocks have historically traded on very high revenue multiples because most are still pre-profitability and the market is pricing in long-duration commercialization potential rather than current earnings power. The exact multiple table was not included in the excerpt reviewed, but the comp set has generally been volatile and sentiment-driven. For IQM, the key question is whether its on-prem system sales, European positioning, and real revenue base justify a premium versus other early-stage quantum hardware names.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
The deal is no longer a watchlist item in the abstract; it is live. IQM is now public as IQMX, and the market will quickly test whether the company’s real system sales and $100 million-plus bookings backlog can support the $1.8 billion valuation. The first thing shareholders should watch is how much cash actually landed on the balance sheet after redemptions and how much dilution came with the PIPE, founder shares, and warrants.
Why this matters now is simple: IQM is one of the few quantum hardware companies with meaningful revenue, deployed systems, and a public listing in a sector that still trades on long-term promise. If the company can keep converting technical credibility into commercial traction, the setup favors a differentiated European quantum platform. If not, the valuation will be judged against a still-early industry with a lot of execution risk and a heavy capital structure.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Picture
Want the full picture on IQMX?
Everything we track on IQMX in one place — the TickerSpark Score, price charts, key financials, and our latest coverage.